Gatibac Eye Dorps
Gatibac sterile eye drops is indicated for the treatment of bacterial infections (e.g. Bacterial conjunctivitis, Blepharitis and Blepharo-conjunctivitis) caused by susceptible strains of the following organisms:
Aerobic Gram-Positive Bacteria
Corynebacterium propinquum, Staphylococcus aureus, Staphylococcus epidermidis,Streptococcus mitis, Streptococcus pneumoniae
Aerobic Gram-Negative Bacteria
Dosage & Administration
Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.
Days 3 through 7: Instill one drop up to four times daily while awake.
NOT FOR INJECTION.
Gatifloxacin solution should not be injected subconjunctivally, nor should it be introduced directly into the anterior chamber of the eye. In patients receiving systemic quinolones, including gatifloxacin, serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, urticaria, and itching.
Use in Pregnancy & Lactation
Pregnancy Category C:
Because there are no adequate and well-controlled studies in pregnant women, gatifloxacin solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when gatifloxacin is administered to a nursing mother.
Pediatric Use: Safety and effectiveness in infants below the age of one year have not been established.
Geriatric Use: No overall differences in safety or effectiveness have been observed between elderly and younger patients.